|
|
||||||||
Papers In Press, published online ahead of print October 1, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 48, 2162-2171, October 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology






* Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia
University of Washington Medical Center, Seattle, WA 98195
Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of five figures.
Published, JLR Papers in Press, July 13, 2007.
1 To whom correspondence should be addressed. e-mail: ghowlett{at}unimelb.edu.au
Serum amyloid P (SAP) is a common component of human amyloid deposits and has been identified in atherosclerotic lesions. We investigated the extent of the colocalization of SAP with apolipoprotein A-I (apoA-I), apoB, apoC-II, and apoE in human coronary arteries and explored potential roles for SAP in these regions, specifically the effect of SAP on the rate of formation and macrophage recognition of amyloid fibrils composed of apoC-II. Analysis of 42 human arterial sections by immunohistochemistry and double label fluorescence microscopy demonstrated that SAP and apoA-I, apoB, apoC-II, and apoE were increased significantly in atherosclerotic lesions compared with nonatherosclerotic segments. SAP colocalized with all four apolipoproteins to a similar extent, whereas plaque macrophages were found to correlate most strongly with apoC-II and apoB. In vitro studies showed that SAP accelerated the formation of amyloid fibrils by purified apoC-II. Furthermore, SAP strongly inhibited the phagocytosis of apoC-II amyloid fibrils by primary macrophages and macrophage cell lines and blocked the resultant production of reactive oxygen species. The ability of SAP to accelerate apoC-II amyloid fibril formation and inhibit macrophage recognition of apoC-II fibrils suggests that SAP may modulate the inflammatory response to amyloid fibrils in atherosclerosis.
Supplementary key words atherosclerosis macrophage immunohistochemistry amyloid
Abbreviations: Aß, ß-amyloid; AEDANS, ({[amino]ethyl}amino)-naphthalene-1-sulfonic acid; apoA-I, apolipoprotein A-I; DIT, diffuse intimal thickening; ROS, reactive oxygen species; SAA, serum amyloid A; SAP, serum amyloid P; ThT, thioflavin T
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. J. Gunzburg, M. A. Perugini, and G. J. Howlett Structural Basis for the Recognition and Cross-linking of Amyloid Fibrils by Human Apolipoprotein E J. Biol. Chem., December 7, 2007; 282(49): 35831 - 35841. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |